The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- Leskelä, S.
- Leandro-García, L.J.
- Mendiola, M.
- Barriuso, J.
- Inglada-Pérez, L.
- Muñoz, I.
- Martínez-Delgado, B.
- Redondo, A.
- De Santiago, J.
- Robledo, M.
- Hardisson, D.
- Rodríguez-Antona, C.
ISSN: 1351-0088, 1479-6821
Argitalpen urtea: 2011
Alea: 18
Zenbakia: 1
Orrialdeak: 85-95
Mota: Artikulua